National Wealth Management Group LLC Buys Shares of 2,853 The Clorox Company (NYSE:CLX)

National Wealth Management Group LLC bought a new stake in The Clorox Company (NYSE:CLX) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,853 shares of the company’s stock, valued at approximately $407,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Wedge Capital Management L L P NC bought a new position in Clorox in the fourth quarter valued at approximately $1,794,000. Mengis Capital Management Inc. raised its holdings in shares of Clorox by 224.2% during the fourth quarter. Mengis Capital Management Inc. now owns 6,579 shares of the company’s stock worth $938,000 after acquiring an additional 4,550 shares during the period. Stock Yards Bank & Trust Co. lifted its position in Clorox by 3.1% in the 4th quarter. Stock Yards Bank & Trust Co. now owns 23,596 shares of the company’s stock valued at $3,365,000 after acquiring an additional 713 shares in the last quarter. Significant Wealth Partners LLC acquired a new position in Clorox in the 4th quarter worth $826,000. Finally, Handelsbanken Fonder AB boosted its stake in Clorox by 100.2% in the 4th quarter. Handelsbanken Fonder AB now owns 56,440 shares of the company’s stock worth $8,048,000 after purchasing an additional 28,245 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

CLX stock traded up $1.64 during trading hours on Monday, reaching $145.19. The stock had a trading volume of 1,292,712 shares, compared to its average volume of 1,203,799. The stock has a market capitalization of $18.02 billion, a PE ratio of 230.46, a price-to-earnings-growth ratio of 2.27 and a beta of 0.43. The stock has a 50-day simple moving average of $149.82 and a 200 day simple moving average of $142.09. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $178.21. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $1.08. The business had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. Clorox’s revenue was up 16.0% on a year-over-year basis. During the same period last year, the business posted $0.98 EPS. Analysts predict that The Clorox Company will post 5.52 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a dividend yield of 3.31%. Clorox’s dividend payout ratio is currently 761.92%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CLX. JPMorgan Chase & Co. lifted their price target on Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a research note on Thursday, January 18th. Morgan Stanley restated an “equal weight” rating and issued a $160.00 target price on shares of Clorox in a research note on Tuesday, March 26th. Barclays reduced their price target on Clorox from $148.00 to $136.00 and set an “underweight” rating for the company in a research report on Wednesday, April 10th. DA Davidson reiterated a “neutral” rating and issued a $162.00 price objective on shares of Clorox in a report on Wednesday, April 17th. Finally, UBS Group boosted their price objective on shares of Clorox from $145.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, February 2nd. Four equities research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $148.63.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.